Genetic modifiers of the severity of sickle cell anemia identified through a genome-wide association study

American Journal of Hematology

Volumn 85, Issue 1, 2010, Pages 29-35

  Sebastiani, Paola ^a   Solovieff, Nadia ^a   Hartley, Stephen W ^a   Milton, Jacqueline N ^a   Riva, Alberto ^b   Dworkis, Daniel A ^c   Melista, Efthymia ^c   Klings, Elizabeth S ^c   Garrett, Melanie E ^d   Telen, Marilyn J ^d   Ashley Koch, Allison ^d   Baldwin, Clinton T ^c   Steinberg, Martin H ^c  

^a BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CHILD; DISEASE ASSOCIATION; DISEASE MODEL; DISEASE SEVERITY; FEMALE; GENE REPLICATION; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC IDENTIFICATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; KCNK6 GENE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REGULATOR GENE; SCHOOL CHILD; SICKLE CELL ANEMIA; SINGLE NUCLEOTIDE POLYMORPHISM; TELOMERE; ADOLESCENT; BIOLOGY; GENETICS; HOSPITALIZATION; MIDDLE AGED; PATHOPHYSIOLOGY; PHENOTYPE;

COMPLEMENT COMPONENT C8; KCNK6 PROTEIN, HUMAN; MAP3K13 PROTEIN, HUMAN; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE; TANDEM PORE DOMAIN POTASSIUM CHANNEL; TANKYRASE; TNKS PROTEIN, HUMAN;

ADOLESCENT; ADULT; ANEMIA, SICKLE CELL; CHILD; COMPLEMENT C8; COMPUTATIONAL BIOLOGY; HUMANS; MAP KINASE KINASE KINASES; MIDDLE AGED; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; POTASSIUM CHANNELS, TANDEM PORE DOMAIN; SEVERITY OF ILLNESS INDEX; TANKYRASES; YOUNG ADULT;

EID: 74049109698     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.21572     Document Type: Article

References (43)

1. Kato GJ, Gladwin MT, Steinberg MH. Deconstructing sickle cell disease: Reappraisal of the role of hemolysis in the development of clinical subphenotypes. Blood Rev 2007;21:37-47.
2. Serjeant GR, Higgs DR, Hambleton IR. Elderly survivors with homozygous sickle cell disease. N Engl J Med 2007;356:642-643.
3. Taylor JG VI, Nolan VG, Mendelsohn L, et al. Chronic hyper-hemolysis in sickle cell anemia: Association of vascular complications and mortality with less frequent vasoocclusive pain. PLoS ONE 2008;3:e2095.
4. Platt OS, Brambilla DJ, Rosse WF, et al. Mortality in sickle cell disease. Life expectancy and risk factors for early death. N Engl J Med 1994;330:1639-1644.
5. Sebastiani P, Nolan VG, Baldwin CT, et al. A network model to predict the risk of death in sickle cell disease. Blood 2007;110:2727-2735.
6. Gaston M, Rosse WF. The cooperative study of sickle cell disease: Review of study design and objectives. Am J Pediatr Hematol Oncol 1982;4:197-201.
7. Anoop P, Bevan DH, Chakrabarti S. Usefulness and limitations of Bayesian network model as a mortality risk assessment tool in sickle cell anemia. Am J Hematol 2009;84:312-313.
8. Sebastiani P, Wang L, Perls TT, et al. A repertoire of genes modifying the risk of death in sickle cell anemia. Blood (ASH Annu Meeting Abstracts) 2007; 110:150.
9. Pearson TA, Manolio TA. How to interpret a genome-wide association study. JAMA 2008;299:1335-1344.
10. Donnelly P. Progress and challenges in genome-wide association studies in humans. Nature 2008;456:728-731.
11. West MS, Wethers D, Smith J, Steinberg M. Laboratory profile of sickle cell disease: A cross-sectional analysis. The Cooperative Study of Sickle Cell Disease. J Clin Epidemiol 1992;45:893-909.
12. Ashley-Koch AE, Elliott L, Kail ME, et al. Identification of genetic polymorphisms associated with risk for pulmonary hypertension in sickle cell disease. Blood 2008;111:5721-5726.
13. Klings ES. Pulmonary hypertension of sickle cell disease: More than just another lung disease. Am J Hematol 2008;83:4-5.
14. Purcell S, Neale B, Todd-Brown K, et al. PLINK: A tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007; 81:559-575.
15. Price AL, Patterson NJ, Plenge RM, et al. Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet 2006; 38:904-909.
16. Balding DJ. A tutorial on statistical methods for population association studies. Nat Rev Genet 2006;7:781-791.
17. Sebastiani P, Zhao Z, Abad-Grau MM, et al. A hierarchical and modular approach to the discovery of robust associations in genome-wide association studies from pooled DNA samples. BMC Genet 2008;9:6.
18. Sebastiani P, Timofeev N, Dworkis DA, et al. Genome-wide association studies and the genetic dissection of complex traits. Am J Hematol 2009;84:504-515.
19. Hosack DA, Dennis G, Sherman BT, et al. Identifying biological themes within lists of genes with EASE. Genome Biol 2003;4:R70.
20. Patterson N, Price AL, Reich D. Population structure and eigenanalysis. PLoS Genet 2006;2:e190.
21. rd Annual Sickle Disease Research and Educational Symposium and Annual National Sickle Cell Disease Scientific Meeting, Ft Lauderdale. Am J Hematol 2009;84:E1-E235.
22. Steinberg MH. Genetic etiologies for phenotypic diversity in sickle cell anemia. ScientificWorldJournal 2009;9:46-67.
23. Hoppe C, Klitz W, Noble J, et al. Distinct HLA associations by stroke subtype in children with sickle cell anemia. Blood 2003;101:2865-2869.
24. Hoppe C, Klitz W, Cheng S, et al. Gene interactions and stroke risk in children with sickle cell anemia. Blood 2004;103:2391-2396.
25. Baldwin C, Nolan VG, Wyszynski DF, et al. Association of klotho, bone morphogenic protein 6, and annexin A2 polymorphisms with sickle cell osteonecrosis. Blood 2005;106:372-375.
26. Nolan VG, Baldwin C, Ma Q, et al. Association of single nucleotide polymorphisms in klotho with priapism in sickle cell anaemia. Br J Haematol 2005; 128:266-272.
27. Sebastiani P, Ramoni MF, Nolan V, et al. Genetic dissection and prognostic modeling of overt stroke in sickle cell anemia. Nat Genet 2005;37:435-440.
28. Nolan VG, Adewoye A, Baldwin C, et al. Sickle cell leg ulcers: Associations with haemolysis and SNPs in klotho, TEK and genes of the TGF-β/BMP pathway. Br J Haematol 2006;133:570-578.
29. Uda M, Galanello R, Sanna S, et al. Genome-wide association study shows BCL11A associated with persistent fetal hemoglobin and amelioration of the phenotype of beta-thalassemia. Proc Natl Acad Sci USA 2008;105:1620-1625.
30. Sedgewick AE, Timofeev N, Sebastiani P, et al. BCL11A is a major HbF quantitative trait locus in three different populations with beta-hemoglobinopathies. Blood Cells Mol Dis 2008;41:255-258.
31. Lettre G, Sankaran VG, Bezerra MA, et al. DNA polymorphisms at the BCL11A, HBS1L-MYB, and beta-globin loci associate with fetal hemoglobin levels and pain crises in sickle cell disease. Proc Natl Acad Sci USA 2008; 105:11869-11874.
32. Klings ES, Safaya S, Adewoye AH, et al. Differential gene expression in pulmonary artery endothelial cells exposed to sickle cell plasma. Physiol Genomics 2005;21:293-298.
33. Hebbel RP, Osarogiagbon R, Kaul D. The endothelial biology of sickle cell disease: Inflammation and a chronic vasculopathy. Microcirculation 2004;11: 129-151.
34. Brugnara C. Red cell membrane in sickle cell disease. In: Steinberg MH, Forget BG, Higgs DR, Nagel RL, editors. Disorders of Hemoglobin: Genetics, Pathophysiology, and Clinical Management. Cambridge: Cambridge University Press; 2001. pp 550-576.
35. Rajashekhar G, Grow M, Willuweit A, et al. Divergent and convergent effects on gene expression and function in acute versus chronic endothelial activation. Physiol Genomics 2007;31:104-113.
36. Goh SH, Josleyn M, Lee YT, et al. The human reticulocyte transcriptome. Physiol Genomics 2007;30:172-178.
37. Donigian JR, De Lange T. The role of the poly(ADP-ribose) polymerase tankyrase1 in telomere length control by the TRF1 component of the shelterin complex. J Biol Chem 2007;282:22662-22667.
38. Erusalimsky JD. Vascular endothelial senescence: From mechanisms to pathophysiology. J Appl Physiol 2009;106:326-332.
39. Erusalimsky JD, Skene C. Mechanisms of endothelial senescence. Exp Physiol 2009;94:299-304.
40. Snyder AR, Zhou J, Deng Z, Lieberman PM. Therapeutic doses of hydroxyurea cause telomere dysfunction and reduce TRF2 binding to telomeres. Cancer Biol Ther 2009;8:1136-1145.
41. Ikeda A, Hasegawa K, Masaki M, et al. Mixed lineage kinase LZK forms a functional signaling complex with JIP-1, a scaffold protein of the c-Jun NH(2)-terminal kinase pathway. J Biochem 2001;130:773-781.
42. Parker CL, Sodetz JM. Role of the human C8 subunits in complement-mediated bacterial killing: Evidence that C8 gamma is not essential. Mol Immunol 2002;39:453-458.
43. Esser AF. The membrane attack complex of complement. Assembly, structure and cytotoxic activity. Toxicology 1994;87:229-247.